Jed Taxel died of rare cancer in 2017, six months after his initial diagnosis. The JEDI Rare Cancer Foundation is his legacy. Our mission and sole commitment is to accelerate scientific discovery that will change lives and enable better outcomes for rare cancer patients and their families.
We are investing in science and building a community of systemic support for concerted, collaborative innovation that will accelerate breakthroughs in rare cancer research, catalyze innovation among collaborators, and bring promising therapeutics to patients to defeat rare cancer. This is something we can and must do.
Meet Mark Taxel Founder, Father & CEO
Your generous donation is an investment in ending rare cancer as we know it.
We accelerate discovery
Comment, Like, Share & Follow Us on Social Media.
Together, we can take action against rare cancer and help save lives.
The Jed Ian Taxel Foundation for Rare Cancer Research | P.O. Box 683501 Park City, Utah 84068
The Jed Ian Taxel Foundation for Rare Cancer Research, Inc. is a 501 (C)(3) Non-Profit Organization, accepting Tax Deductible donations from individuals, corporations, family-advised funds and foundations. Federal Tax ID 86-2610819
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.